Nimish Gera

Nimish Gera, PhD

Nimish Gera, PhD joined Mythic Therapeutics in October 2017 as the scientific co-founder and director of R&D, and now serves as Vice President, Head of Biologics, overseeing the Company’s pipeline and leading a group focused on antibody discovery, engineering, and optimization, protein sciences, ADC generation and cell-based screening technologies.

Nimish’s broad experience in biotech encompasses various modalities (monoclonal antibodies, bispecific antibodies, protein-fusions, and antibody-drug conjugates) and therapeutic areas (oncology, immuno-oncology, autoimmune, and rare disease). Nimish served as a scientist, project leader and principal investigator at Alexion Pharmaceuticals, where he led and managed diverse cross-functional project teams to lead two bispecific antibody programs into development. Prior to Alexion, Nimish helped establish discovery sciences function at Oncobiologics (now Sonnet BioTherapeutics) and identified multiple lead candidates for the company’s platform.

He earned a PhD in chemical and biomolecular engineering with a minor in biotechnology at North Carolina State University.